Open AccessEfficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis
Author(s) -
Avirupa Ghose,
Promod S Bhende,
Jyotirmoy Biswas
Publication year - 2016
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/0301-4738.194335
Subject(s) - medicine , triamcinolone acetonide , acetonide , ophthalmology , choroiditis , dermatology
Active serpiginous choroiditis (SC) is a vision-threatening condition which requires intensive treatment using corticosteroids and/or immunosuppressives, especially if the lesions are involving or encroaching on the macula. Use of oral and intravenous high-dose steroids are contraindicated in uncontrolled diabetics. Intravitreal steroid delivers a localized dose in such situations. This case report highlights the efficacy of reduced dose of intravitreal triamcinolone acetonide (2 mg) in the treatment of active SC.